Skip to content
Screener

Axcelis Technologies ACLS Business Segments — Sales & Marketing

Similar metrics at other companies

Theravance Biopharma logo
TBPHSingle Reportable — Sales & Marketing
$6.91M-5.4%
Research Solutions logo
RSSSSingle Reportable — Sales & Marketing
$1.51M-6.1%
908 Devices logo
MASSSingle Reportable — Sales & Marketing
$4.27M-12.5%
SES AI logo
SESSingle Reportable — Sales & Marketing
$497K+166%
Merit Medical Systems logo
MMSISingle Reportable — Sales & Marketing
$73.96M+13.9%
Vertex, Inc. logo
VERXSingle Reportable — Sales & Marketing
$52.64M+9.3%

Other financials

Income statement

See full
Revenue$215.2M+10.6%
Gross profit$91.2M+4.4%
Operating income$20.3M-30.0%
Net income$23.3M-25.8%
EPS (diluted)$0.75-23.5%

Balance sheet

See full
Cash & equivalents$155.0M-10.7%
Total debt$71.5M-2.5%
Total equity$1.1B+4.2%
Total assets$1.4B+4.8%

Cash flow

See full
Operating cash flow$18.4M-53.8%
CapEx$3.6M+79.0%
Free cash flow$14.8M-60.7%

Valuation

See full
Market cap$4.2B+76.5%
Enterprise value$4.12B+80.7%
P/E45.3×+30.3×
P/S4.9×+2.2×

Profitability

See full
Gross margin43%-1.9pp
Operating margin10.3%-7.5pp
Net margin10.7%-7.0pp
FCF margin8.6%-5.1pp

Returns & leverage

See full
Return on equity8.9%-7.3pp
Debt / equity0.1×0.0×
Current ratio4.9×-1.1×

Where this comes from

Reported directly by Axcelis Technologies in its filing.

Tagged under the XBRL concept us-gaap:SellingAndMarketingExpense.

The source filing: Axcelis Technologies’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:10 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001104659-26-091999
Line itemThree months ended / June 30, 2026Three months ended / June 30, 2025Six months ended / June 30, 2026Six months ended / June 30, 2025
Gross profit91,18987,343171,770176,111
Operating expenses:
Research and development28,97727,06457,49354,192
Sales and marketing19,55415,00336,90830,127
General and administrative22,37716,31149,13833,668
Total operating expenses70,90858,378143,539117,987
Income from operations20,28128,96528,23158,124
Other income (expense):

Item 1. Financial Statements (Unaudited)

FAQ

What is Axcelis Technologies's business segments — sales & marketing?
Axcelis Technologies (ACLS) reported business segments — sales & marketing of $19.55M in Q2 2026.
How has Axcelis Technologies's business segments — sales & marketing changed year-over-year?
Axcelis Technologies's business segments — sales & marketing increased by 30.3% year-over-year, from $15M to $19.55M.
What is the long-term trend for Axcelis Technologies's business segments — sales & marketing?
Over 3 years (2022 to 2025), Axcelis Technologies's business segments — sales & marketing has grown at a 6.8% compound annual growth rate (CAGR), from $53.6M to $65.37M.
What does business segments — sales & marketing mean?
This metric includes costs associated with sales commissions, advertising, trade shows, and customer support activities aimed at promoting and selling semiconductor equipment. It provides insight into the company's investment in customer acquisition and the effectiveness of its go-to-market strategy.

Ask your AI about Axcelis Technologies's business segments — sales & marketing.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude